Park Ha Biological Technology is trading 8.16% up at $2.65, with no verified clear catalyst identified.

  • No verified September 22, 2026 company announcement, earnings release, filing, or other clear catalyst was identified.
  • Recent coverage focuses on securities-class-action reminders ahead of the September 28 deadline, but those reports do not explicitly explain the current gain.